NCT02740829View on ClinicalTrials.gov

Assessment of Intranasal Glucagon on Endogenous Glucose Production

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions
Diabetes
Interventions
DRUG

Intranasal glucagon

Glucagon will be administered via a nasal dispenser

DRUG

Intranasal placebo

Placebo

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02740829 - Assessment of Intranasal Glucagon on Endogenous Glucose Production | Biotech Hunter | Biotech Hunter